Product

VDA-1102

1 clinical trial

1 indication

Indication

Actinic Keratosis

Clinical trial

Randomized, Double-Blind, Placebo-Controlled, Parallel-Cohort Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Once-Daily Application of Topical VDA-1102 Ointment for 28 Days in Subjects With Actinic Keratosis

Status: Completed, Estimated PCD: 2017-05-26